Tag Archives: Annals of Internal Medicine

When the World Health Organization called for earlier initiation of antiretroviral therapy, there was considerable hand-wringing among health economists about the increased costs associated with millions of additional HIV patients who would be newly eligible for HIV drugs under the revised treatment guidelines. But a new study in the Annals of Internal Medicine suggests, among […]

An editorial due out next week in the Annals of Internal Medicine raises a provocative new question about the recent study of PEPFAR’s effectiveness. The initial study, by Stanford researchers Eran Bendavid and Jayanta Bhattacharya, found that while PEPFAR decreased the HIV/AIDS death toll in targeted countries by more than 10 percent between 2004 and […]

How effective is PEPFAR? That’s been a contentious question of late. Now, a new study highlights one stunning success, and another troubling failure, of the global AIDS programs started by ex-President George W. Bush in 2003. First, the good news: PEPFAR decreased the HIV/AIDS death toll in targeted countries by more than 10 […]